HI
CRSP icon

Harbour Investments’s CRISPR Therapeutics CRSP Stock Holding History

Harbour Investments’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
3,533
+44
+1% +$2.32K ﹤0.01% 1623
2026
Q1 		$166K Buy
3,489
+1,622
+87% +$85.5K ﹤0.01% 1632
2025
Q4 		$97.9K Sell
1,867
-7
-0.4% -$419 ﹤0.01% 1648
2025
Q3 		$121K Buy
1,874
+599
+47% +$34.4K ﹤0.01% 1493
2025
Q2 		$62K Sell
1,275
-136
-10% -$5.26K ﹤0.01% 1712
2025
Q1 		$48K Sell
1,411
-306
-18% -$13K ﹤0.01% 1791
2024
Q4 		$67.6K Sell
1,717
-350
-17% -$16.5K ﹤0.01% 1569
2024
Q3 		$97.1K Sell
2,067
-139
-6% -$7.05K ﹤0.01% 1330
2024
Q2 		$119K Buy
2,206
+389
+21% +$22.5K ﹤0.01% 1163
2024
Q1 		$124K Buy
1,817
+236
+15% +$16.9K ﹤0.01% 1114
2023
Q4 		$99K Sell
1,581
-114
-7% -$6.3K ﹤0.01% 1141
2023
Q3 		$76.9K Buy
1,695
+4
+0.2% +$207 ﹤0.01% 1146
2023
Q2 		$94.9K Buy
1,691
+60
+4% +$3.4K ﹤0.01% 1083
2023
Q1 		$73.8K Hold
1,631
– – ﹤0.01% 1182
2022
Q4 		$66.3K Sell
1,631
-61
-4% -$3.24K ﹤0.01% 1186
2022
Q3 		$103K Hold
1,692
– – 0.01% 949
2022
Q2 		$103K Buy
+1,692
New +$99.5K 0.01% 949
2021
Q4 		$113K Buy
1,491
+952
+177% +$83.2K 0.01% 922
2021
Q3 		$60K Buy
539
+54
+11% +$6.78K ﹤0.01% 1658
2021
Q2 		$79K Sell
485
-39
-7% -$4.74K ﹤0.01% 1526
2021
Q1 		$64K Buy
+524
New +$79.1K ﹤0.01% 1530

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Harbour Investments's CRSP Position: Q2 2026 in Review

Harbour Investments increased its CRISPR Therapeutics (CRSP) stake by 1.3% in Q2 2026, buying an estimated $2.32K and bringing the position to 3,533 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

Harbour Investments first reported a position in CRSP in Q1 2021 and has held it in 21 quarters since. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Harbour Investments held 3,533 shares of CRISPR Therapeutics worth $193K as of Q2 2026.
  • Harbour Investments bought 44 CRISPR Therapeutics shares in Q2 2026, an estimated $2.32K.
  • CRISPR Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1623 holding.
  • Harbour Investments first reported a position in CRISPR Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.